Project description:we have performed transcriptomic analysis of colonic samples of mice challenged with DNBS twice in a chronic model of inflammation and treated with CNCM -I3690 strain and several mutants and variants generated from it. colonic transcriptome analysis at the endpoint revealed that CNCM I 3690 enhances the expression of genes related to healthy gut permeability, motility (Ghrelin (GHR)), and absorption (guanylate cyclase activator 2B (Guca 2b)); cell proliferation (amino acid transporter SLC7A7); and protective functions (endogenous protease inhibitor kazal-type4). Focusing on inflammation, both GHR and Guca 2B have been found to act as anti-inflammatory, protecting the gut against a wide range of threats. Besides, CNCM I-3690 also up regulated TRAF-interaction protein with a forkhead-associated domain (TIFA), an important signaling adaptor in the NF-κβ pathway.

2019-04-17 | GSE101411 | GEO

Companilactobacillus farciminis strain:LMG9189, NRIC0416, NRIC0417, KB1089

Project description:Draft genome of Lactobacillus farciminis

| PRJDB7600 | ENA

Companilactobacillus farciminis KCTC 3681 = DSM 20184

Project description:Lactobacillus farciminis KCTC 3681 genome sequencing

| PRJNA61183 | ENA

Companilactobacillus farciminis KCTC 3681 = DSM 20184

Project description:The whole genome sequencing and assembly of L. farciminis DSM 20184

| PRJNA348651 | ENA

Enzyme systems involved in glucosinolate metabolism in Companilactobacillus farciminis KB1089.

Project description: Not available